FARMACEUTISK LABORATORIUM FERRING A/S: Financial statements 2013
CVR: 62664819
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
FARMACEUTISK LABORATORIUM FERRING A/S (CVR 62664819) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -2,462,000 compared with DKK -7,572,000 the year before. Equity in the 2013 report amounted to DKK 6,085,000. The solvency ratio was 8.5%.
- Profit/Loss
- DKK -2,462,000
- Equity
- DKK 6,085,000
- Total Assets
- DKK 71,987,000
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
FARMACEUTISK LABORATORIUM FERRING A/S has published its annual report for 2012. The net result was DKK -7,572,000.
As of January 1, 2013, is registered as an owner of FARMACEUTISK LABORATORIUM FERRING A/S with an ownership share of 100%.
About FARMACEUTISK LABORATORIUM FERRING A/S
FARMACEUTISK LABORATORIUM FERRING A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1956. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marianne Kock. The board consists of Jeffrey Douglas McConaghy (chair), Marianne Kock and Pierre-Jerome Blain. The company is owned by Ferring B.V.. The company has 0 employees (2009). In 2025, the company reported a gross profit of DKK 751,000 and a net result of DKK 100,851,000 compared with DKK -4,904,000 the year before. Equity in the 2025 report amounted to DKK -206,358,000.
